What is the emergency management of hypotension in a patient with heart failure with reduced ejection fraction (HFrEF)?

Emergency Management of HFrEF with Hypotension

In acute HFrEF with hypotension, immediately assess for cardiogenic shock (SBP <90 mmHg with organ hypoperfusion); if shock is present, initiate fluid challenge (250-500 mL over 15-30 minutes), followed by dobutamine as first-line inotrope with norepinephrine added only if vasopressor support is needed, while DO NOT routinely discontinue guideline-directed medical therapy (GDMT) unless SBP <80 mmHg with severe symptoms. 1, 2

Initial Assessment: Distinguish True Emergency from Benign Hypotension

The critical first step is determining whether hypotension represents true cardiogenic shock or simply low blood pressure readings without end-organ compromise:

Signs of Cardiogenic Shock (TRUE EMERGENCY):

• SBP <90 mmHg for >30 minutes despite adequate volume
• Organ hypoperfusion markers:
  • Oliguria (<0.5 mL/kg/h for ≥6 hours)
  • Altered mental status
  • Cold extremities with livedo reticularis
  • Lactate >2 mmol/L
  • Metabolic acidosis
  • SvO2 <65% 2

Benign Hypotension (NOT an emergency):

• Low BP readings without hypoperfusion symptoms
• Patient asymptomatic or only mild dizziness
• Normal organ function maintained 1

Critical pitfall: In early cardiogenic shock, BP may be maintained through compensatory vasoconstriction while tissue hypoperfusion is already occurring—don't wait for profound hypotension to act. 1

Emergency Management Algorithm for TRUE Cardiogenic Shock

Step 1: Immediate Interventions

• ECG and echocardiography immediately to identify reversible causes (acute MI, mechanical complications, tamponade) 2
• Arterial line placement for continuous BP monitoring 2
• Fluid challenge first: 250-500 mL saline or Ringer's lactate over 15-30 minutes if no overt fluid overload 2, 3

Step 2: Pharmacologic Support

Inotrope selection:

• Dobutamine is first-line inotrope to increase cardiac output 2, 3, 4
• Levosimendan may be considered especially if patient on chronic beta-blockers 2

Vasopressor use (only if persistent hypoperfusion despite inotropes):

• Norepinephrine is preferred over dopamine if vasopressor needed 2, 3
• Use vasopressors sparingly—only when strictly necessary to maintain perfusion pressure 2

Step 3: Immediate Transfer

• Transfer to tertiary center with 24/7 cardiac catheterization and ICU with mechanical circulatory support capability 2
• IABP is NOT routinely recommended 2
• Short-term mechanical circulatory support (Impella, ECMO, TandemHeart) may be considered based on age, comorbidities, and neurological function 2

Management of Non-Shock Hypotension in Acute HFrEF

For patients with SBP 80-90 mmHg without shock or symptomatic hypotension:

Acute Setting Approach:

1. Assess clinical phenotype using Forrester classification 1:

   • "Wet and warm" (congested, well-perfused): Continue GDMT, treat congestion with diuretics/vasodilators
   • "Wet and cold" (congested, hypoperfused): May need to temporarily reduce/hold GDMT, especially beta-blockers 1
   • "Dry and cold" (hypoperfused, not congested): Fluid challenge, may need to hold GDMT temporarily 1

2. DO NOT automatically discontinue GDMT 1:

   • Recent data shows patients with low SBP but no hypoperfusion have similar prognosis to normal SBP patients 1
   • BP alone is insufficient to guide therapy 1

3. If GDMT adjustment needed (SBP <80 mmHg with major symptoms):

   • First: Stop non-HF cardiac medications (calcium channel blockers, alpha-blockers, centrally acting antihypertensives) 1
   • Second: Reduce diuretics if no congestion present 1
   • Third: Among GDMT drugs, reduce the least well-tolerated medication first 1
   • Preserve SGLT2 inhibitors and MRAs as they have minimal BP-lowering effect and may actually increase BP 1

Management of Chronic/Ambulatory Hypotension in HFrEF

For non-emergency outpatient hypotension:

Initial Assessment:

1. Verify BP readings (supine and standing) 1
2. Assess for orthostatic hypotension: Drop of 20 mmHg SBP or 10 mmHg DBP within 3 minutes of standing 1
3. Identify reversible causes:
   • Dehydration (diarrhea, fever, overdiuresis)
   • Non-HF hypotensive medications
   • Volume depletion 1

Treatment Strategy:

Asymptomatic or mildly symptomatic low BP should NEVER be reason for GDMT reduction 1

For persistent symptomatic hypotension:

1. Reduce/stop non-HF cardiac medications first
2. Adjust diuretics if no congestion
3. Consider midodrine (alpha-1 agonist) as bridge therapy to allow GDMT optimization 5, 6
4. Refer to HF specialist if unable to optimize GDMT 1

GDMT Sequencing in Treatment-Naïve Patients with Low BP:

Start with drugs that have least BP effect: 1

1. SGLT2 inhibitors + MRAs first (minimal BP effect, rapid benefit)
2. Then add low-dose beta-blocker (if HR >70 bpm) OR very low-dose sacubitril/valsartan (25 mg BID)
3. Prefer selective β1-blockers over non-selective agents (less BP lowering)
4. Consider ivabradine if beta-blockers not tolerated hemodynamically 1

Key Thresholds and Decision Points

• SBP <80 mmHg with major symptoms: Initiate GDMT down-titration 1
• SBP 80-90 mmHg asymptomatic: Continue full GDMT 1
• SBP <90 mmHg with organ hypoperfusion >30 min: Cardiogenic shock—initiate emergency protocol 2

Critical Pitfalls to Avoid

1. Don't reflexively stop GDMT for low BP numbers alone—assess perfusion and symptoms 1
2. Don't use IABP routinely in cardiogenic shock—evidence doesn't support benefit 2
3. Don't choose dopamine over norepinephrine if vasopressor needed 2
4. Don't forget to reassess and restart GDMT once BP improves—prioritize best-tolerated agents first 1
5. Don't delay specialist referral if persistent hypotension prevents GDMT optimization 1